XML 45 R34.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
Assets and liabilities measured at fair value on a recurring basis as of March 31, 2025 and December 31, 2024 are summarized below:

Fair Value Measure on a Recurring Basis
($ in thousands)Total
Fair Value
Quoted
Prices in
Active Markets
(Level 1)
Significant Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
March 31, 2025
Assets:
U.S. Government agencies or sponsored agency securities:
Residential mortgage-backed securities$36,398 $— $36,398 $— 
Residential collateralized mortgage obligations140,576 — 140,576 — 
Municipal securities - tax exempt5,506 — 5,506 — 
Other investments:
Mutual fund - CRA qualified3,612 3,612 — — 
Derivative financial instruments124 — 124 — 
Liabilities:
Derivative financial instruments$883 $— $883 $— 
December 31, 2024
Assets:
U.S. Government agencies or sponsored agency securities:
Residential mortgage-backed securities$37,076 $— $37,076 $— 
Residential collateralized mortgage obligations143,041 — 143,041 — 
Municipal securities - tax exempt5,792 — 5,792 — 
Other investments:
Mutual fund - CRA qualified3,532 3,532 — — 
Derivative financial instruments368 — 368 — 
Liabilities:
Derivative financial instruments$579 $— $579 $— 
Schedule of Fair Value Hierarchy and Fair Value of Assets that Were Still Held and Had Fair Value Adjustments Measured On a Nonrecurring Basis
The following table presents the fair value hierarchy and fair value of assets that were still held and had fair value adjustments measured on a nonrecurring basis as of March 31, 2025 and December 31, 2024:

Fair Value Measure on a Nonrecurring Basis
($ in thousands)Total
Fair Value
Quoted
Prices in
Active Markets
(Level 1)
Significant Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
March 31, 2025
Collateral-dependent loans:
Commercial real estate$222 $— $— $222 
SBA—real estate1,393 — — 1,393 
Total$1,615 $— $— $1,615 
December 31, 2024
Collateral-dependent loans:
Commercial real estate$173 $— $— $173 
SBA—real estate952 — — 952 
OREO1237 — — 1237 
Total$2,362 $— $— $2,362 
Total
Schedule of Increase (Decrease) In Value of Certain Assets Held at End of Respective Reporting Periods Presented for Which a Nonrecurring Fair Value Adjustment
The following table presents the increase (decrease) in value of certain assets held at the end of the respective reporting periods presented for which a nonrecurring fair value adjustment was recognized during the period presented:
Three Months Ended March 31,
($ in thousands)20252024
Collateral-dependent loans:
Commercial real estate$49 $— 
SBA—real estate274 — 
Total$323 $— 
Schedule of Information about Significant Unobservable Inputs Utilized in Company's Nonrecurring Level 3 Fair Value Measurements
The following table presents information about significant unobservable inputs utilized in the Company’s nonrecurring Level 3 fair value measurements as of March 31, 2025 and December 31, 2024:

($ in thousands)Fair Value
Measurements
(Level 3)
Valuation
Techniques
Unobservable
Inputs
Range of
Inputs
Weighted-
Average of
Inputs(1)
March 31, 2025
Collateral-dependent loans:
Commercial real estate$222 
Income approach - income capitalization
Capitalization rate
5.5% to 7.3%
6.0%
SBA—real estate948 
Income approach - income capitalization
Capitalization rate
5.5% to 9.0%
6.7%
SBA—real estate278 Sales comparison approachMarket data comparison
0.0% to 35.0%
4.7%
SBA—real estate167 Cost approachReplacement cost estimates
1.23x for building / 0.0% to 36.0% for land
1.23x for building / 26.2% for land
December 31, 2024
Collateral-dependent loans:
Commercial real estate$173 Income approach - income capitalizationCapitalization rate
5.5% to 7.3%
6.0%
SBA—real estate539 Income approach - income capitalizationCapitalization rate
5.5% to 7.3%
10.4%
SBA—real estate413 Sales comparisonMarket data / purchase pricen/an/a
OREO$1,237 Sales comparison approachMarket data comparison
(3.7)% to 2.2%
(0.5)%
(1)Weighted-average of inputs is based on the relative fair value of the respective assets as of March 31, 2025 and December 31, 2024.
Schedule of Carrying Amounts and Estimated Fair Values of Financial Instruments Not Carried at Fair Value
Financial Instruments: The carrying amounts and estimated fair values of financial instruments that are not carried at fair value on a recurring basis as of March 31, 2025 and December 31, 2024 are as follows. These financial assets and liabilities are measured at amortized cost basis on the Company’s Consolidated Balance Sheets:

March 31, 2025
($ in thousands)Carrying
Amount
Level 1Level 2Level 3Fair Value
Financial assets:
Cash and cash equivalents$198,861 $198,861 $— $— $198,861 
Loans held for sale4,555 — 4,916 — 4,916 
Loans receivable, net2,018,517 — — 2,083,302 2,083,302 
Accrued interest receivable, net9,871 471 814 8,586 9,871 
Other investments:
FHLB and PCBB stock12,805 N/AN/AN/AN/A
Time deposits placed100 — 100 — 100 
Financial liabilities:
Deposits2,189,871 — 2,191,005 — 2,191,005 
FHLB advances75,000 — 74,998 — 74,998 
Accrued interest payable14,994 — 14,994 — 14,994 
December 31, 2024
($ in thousands)Carrying
Amount
Level 1Level 2Level 3Fair Value
Financial assets:
Cash and cash equivalents$134,943 $134,943 $— $— $134,943 
Loans receivable, net1,932,056 — — 1,986,813 1,986,813 
Accrued interest receivable, net9,188 181 888 8,119 9,188 
Other investments:
FHLB and PCBB stock12,805 N/AN/AN/AN/A
Time deposits placed100 — 100 — 100 
Financial liabilities:
Deposits2,027,285 — 2,026,092 — 2,026,092 
FHLB advances95,000 — 94,986 — 94,986 
Accrued interest payable16,067 — 16,067 — 16,067